首页 /科研细胞 /科研细胞 /科研细胞 /HMy2.CIR(人B淋巴母细胞瘤细胞)

HMy2.CIR(人B淋巴母细胞瘤细胞)

CBP60725

询 价
索取STR
产品描述
产品数据库
I. General information 
Synonyms: HMy2.CIR
Background: The HMy2.CIR cell line was derived from the HMy.2 B lymphoblastoid cell line, a fast growing mutant of the ARH-77 cell line (ATCC CRL-1621), by gamma irradiation and selection for loss of HLA class I antigen expression.
Morphology: lymphoblast
Growth Mode: suspension
Doubling Time:  N/A
DNA Profile: Amelogenin: X
CSF1PO: 6,10
D13S317: 11,13
D16S539: 9,13
D5S818: 10,13
D7S820: 7,12
THO1: 8
TPOX: 8
vWA: 1
Cobioer’s Cell Line Authentication Service
Culture Medium:

RPMI-1640+10%FBS

HMy2.CIR完全培养基,# CBP60725M
We strongly suggest to purchase the complete medium from Cobioer.

Cryopreservation medium: 90%FBS+10%DMSO
Antigen Expression: The CRL-1621cell line is reported to be positive for Epstein-Barr nuclear antigen (EBNA +) and Epstein-Barr viral capsid antigen (EBVCA +). 
Genes Expressed:  The cells express no HLA A or B locus products, but do express small amounts of HLA Cw4.
Comments: The cells are useful as host for transfected class I major histocompatibility antigen genes.
Since the HMy2.CIR cell line was derived from the HMy.2 B lymphoblastoid cell line, a fast growing mutant of the ARH-77 cell line (ATCC CRL-1621), it is assumed to be EBNA positive.
For more information, please contact Cobioer (4008-750-250).
药靶模型联系方式: 华东销售经理:18240630236 全国销售经理:18066071954
诊断标准品联系方式: 华东销售经理:15000320447 华北销售经理:18131625521 华南销售经理:13484295986 华中&西南销售经理:13871580511 全国销售经理:13484295986

扫二维码

立即提交